242 related articles for article (PubMed ID: 27792127)
1. Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors.
Bii VM; Trobridge GD
Cancers (Basel); 2016 Oct; 8(11):. PubMed ID: 27792127
[TBL] [Abstract][Full Text] [Related]
2. Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes.
Bii VM; Collins CP; Hocum JD; Trobridge GD
Oncotarget; 2018 Mar; 9(21):15451-15463. PubMed ID: 29643985
[TBL] [Abstract][Full Text] [Related]
3. A novel approach to identify driver genes involved in androgen-independent prostate cancer.
Schinke EN; Bii V; Nalla A; Rae DT; Tedrick L; Meadows GG; Trobridge GD
Mol Cancer; 2014 May; 13():120. PubMed ID: 24885513
[TBL] [Abstract][Full Text] [Related]
4. Mutagenesis Screens for Prostate Cancer Using Replication-Incompetent Lentiviral Vectors.
Trobridge GD
Methods Mol Biol; 2019; 1907():103-114. PubMed ID: 30542994
[TBL] [Abstract][Full Text] [Related]
5. A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker.
Bii VM; Rae DT; Trobridge GD
Oncotarget; 2015 Nov; 6(37):39507-20. PubMed ID: 26506596
[TBL] [Abstract][Full Text] [Related]
6. Identification of Hematopoietic Stem Cell Engraftment Genes in Gene Therapy Studies.
Powers JM; Trobridge GD
J Stem Cell Res Ther; 2013 Sep; 2013(Suppl 3):S3:004-. PubMed ID: 24383045
[TBL] [Abstract][Full Text] [Related]
7. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
8. The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery.
Anson DS
Genet Vaccines Ther; 2004 Aug; 2(1):9. PubMed ID: 15310406
[TBL] [Abstract][Full Text] [Related]
9. Insertional mutagenesis by replication-deficient retroviral vectors encoding the large T oncogene.
Li Z; Kustikova OS; Kamino K; Neumann T; Rhein M; Grassman E; Fehse B; Baum C
Ann N Y Acad Sci; 2007 Jun; 1106():95-113. PubMed ID: 17395733
[TBL] [Abstract][Full Text] [Related]
10. Cancer gene discovery: exploiting insertional mutagenesis.
Ranzani M; Annunziato S; Adams DJ; Montini E
Mol Cancer Res; 2013 Oct; 11(10):1141-58. PubMed ID: 23928056
[TBL] [Abstract][Full Text] [Related]
11. Insulators to Improve the Safety of Retroviral Vectors for HIV Gene Therapy.
Browning DL; Trobridge GD
Biomedicines; 2016 Mar; 4(1):. PubMed ID: 28424756
[TBL] [Abstract][Full Text] [Related]
12. VISA--Vector Integration Site Analysis server: a web-based server to rapidly identify retroviral integration sites from next-generation sequencing.
Hocum JD; Battrell LR; Maynard R; Adair JE; Beard BC; Rawlings DJ; Kiem HP; Miller DG; Trobridge GD
BMC Bioinformatics; 2015 Jul; 16(1):212. PubMed ID: 26150117
[TBL] [Abstract][Full Text] [Related]
13. Using retroviruses as a mutagenesis tool to explore the zebrafish genome.
Jao LE; Maddison L; Chen W; Burgess SM
Brief Funct Genomic Proteomic; 2008 Nov; 7(6):427-43. PubMed ID: 18977782
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gene-trapping efficiency between retroviral and lentiviral vectors in mouse embryonic stem cells.
Yamaguchi T; Morikawa A; Miyoshi H
Biochem Biophys Res Commun; 2012 Aug; 425(2):297-303. PubMed ID: 22842569
[TBL] [Abstract][Full Text] [Related]
15. Engineering Next-Generation BET-Independent MLV Vectors for Safer Gene Therapy.
El Ashkar S; Van Looveren D; Schenk F; Vranckx LS; Demeulemeester J; De Rijck J; Debyser Z; Modlich U; Gijsbers R
Mol Ther Nucleic Acids; 2017 Jun; 7():231-245. PubMed ID: 28624199
[TBL] [Abstract][Full Text] [Related]
16. A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis.
Rae DT; Hocum JD; Bii V; Deeg HJ; Trobridge GD
Oncotarget; 2015 Oct; 6(31):30664-74. PubMed ID: 26384344
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer.
Ranzani M; Cesana D; Bartholomae CC; Sanvito F; Pala M; Benedicenti F; Gallina P; Sergi LS; Merella S; Bulfone A; Doglioni C; von Kalle C; Kim YJ; Schmidt M; Tonon G; Naldini L; Montini E
Nat Methods; 2013 Feb; 10(2):155-61. PubMed ID: 23314173
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
19. High-throughput insertional mutagenesis screens in mice to identify oncogenic networks.
Kool J; Berns A
Nat Rev Cancer; 2009 Jun; 9(6):389-99. PubMed ID: 19461666
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
